These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 23752138)

  • 1. Chronic kidney disease and the foot in diabetes--is inflammation the missing link?
    Game FL; Selby NM; McIntyre CW
    Nephron Clin Pract; 2013; 123(1-2):36-40. PubMed ID: 23752138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney diseases in Africa: aetiological considerations, peculiarities and burden.
    Okunola O; Akinsola A; Ayodele O
    Afr J Med Med Sci; 2012 Jun; 41(2):119-33. PubMed ID: 23185909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on haemodialysis.
    Kaminski M; Frescos N; Tucker S
    Intern Med J; 2012 Jun; 42(6):e120-8. PubMed ID: 21999812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foot problems in patients with diabetes and chronic kidney disease.
    Valabhji J
    J Ren Care; 2012 Feb; 38 Suppl 1():99-108. PubMed ID: 22348369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients.
    Tsai JC; Chen SC; Hwang SJ; Chang JM; Lin MY; Chen HC
    Am J Kidney Dis; 2010 May; 55(5):856-66. PubMed ID: 20153917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal association between the incidence of foot ulceration and the start of dialysis in diabetes mellitus.
    Game FL; Chipchase SY; Hubbard R; Burden RP; Jeffcoate WJ
    Nephrol Dial Transplant; 2006 Nov; 21(11):3207-10. PubMed ID: 16877485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of risk factors for foot ulceration in individuals with chronic kidney disease.
    Freeman A; May K; Frescos N; Wraight PR
    Intern Med J; 2008 May; 38(5):314-20. PubMed ID: 18005131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal failure: implications of chronic kidney disease in the management of the diabetic foot.
    Lewis S; Raj D; Guzman NJ
    Semin Vasc Surg; 2012 Jun; 25(2):82-8. PubMed ID: 22817857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrorenal interaction and stroke.
    Toyoda K
    Contrib Nephrol; 2013; 179():1-6. PubMed ID: 23676853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron status and chronic kidney disease predict restless legs syndrome in an older hospital population.
    Quinn C; Uzbeck M; Saleem I; Cotter P; Ali J; O'Malley G; Gilmartin JJ; O'Keeffe ST
    Sleep Med; 2011 Mar; 12(3):295-301. PubMed ID: 21317036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study.
    Panuccio V; Enia G; Tripepi R; Aliotta R; Mallamaci F; Tripepi G; Zoccali C
    BMC Nephrol; 2012 Oct; 13():134. PubMed ID: 23043229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Egypt Information, Prevention, and Treatment of Chronic Kidney Disease (EGIPT-CKD) programme: prevalence and risk factors for microalbuminuria among the relatives of patients with CKD in Egypt.
    Gouda Z; Mashaal G; Bello AK; El Attar A; El Kemmry T; El Reweny A; El Nahas M
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1055-63. PubMed ID: 21912051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of stroke in kidney disease.
    Ninomiya T
    Contrib Nephrol; 2013; 179():58-66. PubMed ID: 23652449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in mainland China: a multicenter cross-sectional study.
    Cao Y; Gong M; Han Y; Xie J; Li X; Zhang L; Li Y; Song X; Zhu T; Li T
    Nephrology (Carlton); 2013 Apr; 18(4):307-12. PubMed ID: 23311442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of chronic kidney disease risk factors in a Louisiana nursing home population: a cross-sectional study.
    Aguilar EA; Ashraf H; Frontini M; Ruiz M; Reske TM; Cefalu C
    J La State Med Soc; 2013; 165(5):260-3, 265-7. PubMed ID: 24350526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation.
    Hering D; Esler MD; Schlaich MP
    EuroIntervention; 2013 May; 9 Suppl R():R127-35. PubMed ID: 23732145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in CKD: what we know and what we need to know.
    Clark LE; Khan I
    Nephron Clin Pract; 2010; 114(2):c95-102. PubMed ID: 19887829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.